tiprankstipranks
Advertisement
Advertisement
Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright
PremiumThe FlyVirax Biolabs price target lowered to $1 from $3 at H.C. Wainwright
3M ago
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target
Premium
Ratings
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target
3M ago
Virax Biolabs files to sell 25.875M ordinary shares for holders
Premium
The Fly
Virax Biolabs files to sell 25.875M ordinary shares for holders
4M ago
Virax completes patient recruitment for its clinical study evaluating ViraxImmun
PremiumThe FlyVirax completes patient recruitment for its clinical study evaluating ViraxImmun
6M ago
Virax Biolabs partners with Emory University on ViraxImmune clinical studies
Premium
The Fly
Virax Biolabs partners with Emory University on ViraxImmune clinical studies
8M ago
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director
Premium
Company Announcements
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director
9M ago
Virax Biolabs Launches Clinical Study on T Cell Dysfunction
PremiumCompany AnnouncementsVirax Biolabs Launches Clinical Study on T Cell Dysfunction
1y ago
Virax Biolabs enrolls first patients in T-cell dysfunction study
Premium
The Fly
Virax Biolabs enrolls first patients in T-cell dysfunction study
1y ago
Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes
Premium
Company Announcements
Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100